Zhuhai Rundu Pharmaceutical Co., Ltd. (SZSE: 002923)
Health Care · Pharmaceuticals · CN
CN¥11.03
+1.66% today · -16.4% 1Y
Zhuhai Rundu Pharmaceutical Co., Ltd. (SZSE: 002923) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $550.68M and employs 1,655 people.
Over the last twelve months the share price has lost 16.4%, trading between 9.02 and 18.96.
Tweenvest scores Zhuhai Rundu Pharmaceutical Co., Ltd. across four factors: quality 69/100, value 45/100, growth 0/100. Its strongest factor is quality.
002923 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $550.68M
- Revenue (TTM)
- $196.85M
- P/E
- 277.83
- EPS
- 0.04
- Dividend yield
- —
- Beta (5Y)
- 0.00
- 52-week high
- CN¥18.96
- 52-week low
- CN¥9.02
- Avg volume (3M)
- —
- Shares outstanding
- 334.89M
- Employees
- 1,655
- Next earnings
- —
About Zhuhai Rundu Pharmaceutical Co., Ltd.
Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical firm established in 1997 and based in Zhuhai, China, is engaged in the research, production, and worldwide distribution of pharmaceutical components. The company's diverse portfolio of medicinal ingredients targets key therapeutic areas such as cardiovascular health, gastrointestinal conditions, central nervous system (CNS) disorders, and anesthesia. Its offerings include Active Pharmaceutical Ingredients (APIs), intermediate compounds, finished dosage forms (FDFs), and pellets, which are supplied in common formats like capsules, tablets, and injectable solutions.
- ISIN
- CNE1000033G8
- Founded
- 1999
- Listed since
- Jan 5, 2018
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kingchem (Liaoning) Life Science Co., Ltd.SZSE: 301509 | $561.13M | CN¥31.25 | +0.19% |
| Huaren Pharmaceutical Co., Ltd.SZSE: 300110 | $558.70M | CN¥3.17 | -8.12% |
| GlaxoSmithKline S.A.ECASE: BIOC | $558.53M | EGP350.11 | +36.94% |
| Nanjing Hicin Pharmaceutical Co., Ltd.SZSE: 300584 | $557.80M | CN¥31.18 | +3.11% |
| Phathom Pharmaceuticals, Inc.NasdaqGS: PHAT | $549.66M | $6.81 | -1.59% |
| Aclaris Therapeutics, Inc.NasdaqGS: ACRS | $544.64M | $3.40 | -8.11% |
| Clarity Pharmaceuticals LtdASX: CU6 | $544.53M | AU$2.10 | -0.47% |
| Oculis Holding AGNasdaqGM: OCS | $538.30M | $8.50 | -2.52% |
Figures last refreshed Oct 4, 2026.